Cargando…
Prediction of False-Positive Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Molecular Results in a High-Throughput Open-Platform System
Widespread high-throughput testing for identification of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection by RT-PCR has been a foundation in the response to the coronavirus disease 2019 (COVID-19) pandemic. Quality assurance metrics for these RT-PCR tests are still evolving as...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Association for Molecular Pathology and American Society for Investigative Pathology. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186061/ https://www.ncbi.nlm.nih.gov/pubmed/34116245 http://dx.doi.org/10.1016/j.jmoldx.2021.05.015 |
_version_ | 1783704886077030400 |
---|---|
author | Martinez, Ryan J. Pankratz, Nathan Schomaker, Matthew Daniel, Jerry Beckman, Kenneth Karger, Amy B. Thyagarajan, Bharat Ferreri, Patricia Yohe, Sophia L. Nelson, Andrew C. |
author_facet | Martinez, Ryan J. Pankratz, Nathan Schomaker, Matthew Daniel, Jerry Beckman, Kenneth Karger, Amy B. Thyagarajan, Bharat Ferreri, Patricia Yohe, Sophia L. Nelson, Andrew C. |
author_sort | Martinez, Ryan J. |
collection | PubMed |
description | Widespread high-throughput testing for identification of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection by RT-PCR has been a foundation in the response to the coronavirus disease 2019 (COVID-19) pandemic. Quality assurance metrics for these RT-PCR tests are still evolving as testing is widely implemented. As testing increases, it is important to understand performance characteristics and the errors associated with these tests. Herein, we investigate a high-throughput, laboratory-developed SARS-CoV-2 RT-PCR assay to determine whether modeling can generate quality control metrics that identify false-positive (FP) results due to contamination. This study reviewed repeated clinical samples focusing on positive samples that test negative on re-extraction and PCR, likely representing false positives. To identify and predict false-positive samples, we constructed machine learning–derived models based on the extraction method used. These models identified variables associated with false-positive results across all methods, with sensitivities for predicting FP results ranging between 67% and 100%. Application of the models to all results predicted a total FP rate of 0.08% across all samples, or 2.3% of positive results, similar to reports for other RT-PCR tests for RNA viruses. These models can predict quality control parameters, enabling laboratories to generate decision trees that reduce interpretation errors, allow for automated reflex testing of samples with a high FP probability, improve workflow efficiency, and increase diagnostic accuracy for patient care. |
format | Online Article Text |
id | pubmed-8186061 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Association for Molecular Pathology and American Society for Investigative Pathology. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81860612021-06-08 Prediction of False-Positive Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Molecular Results in a High-Throughput Open-Platform System Martinez, Ryan J. Pankratz, Nathan Schomaker, Matthew Daniel, Jerry Beckman, Kenneth Karger, Amy B. Thyagarajan, Bharat Ferreri, Patricia Yohe, Sophia L. Nelson, Andrew C. J Mol Diagn Regular Article Widespread high-throughput testing for identification of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection by RT-PCR has been a foundation in the response to the coronavirus disease 2019 (COVID-19) pandemic. Quality assurance metrics for these RT-PCR tests are still evolving as testing is widely implemented. As testing increases, it is important to understand performance characteristics and the errors associated with these tests. Herein, we investigate a high-throughput, laboratory-developed SARS-CoV-2 RT-PCR assay to determine whether modeling can generate quality control metrics that identify false-positive (FP) results due to contamination. This study reviewed repeated clinical samples focusing on positive samples that test negative on re-extraction and PCR, likely representing false positives. To identify and predict false-positive samples, we constructed machine learning–derived models based on the extraction method used. These models identified variables associated with false-positive results across all methods, with sensitivities for predicting FP results ranging between 67% and 100%. Application of the models to all results predicted a total FP rate of 0.08% across all samples, or 2.3% of positive results, similar to reports for other RT-PCR tests for RNA viruses. These models can predict quality control parameters, enabling laboratories to generate decision trees that reduce interpretation errors, allow for automated reflex testing of samples with a high FP probability, improve workflow efficiency, and increase diagnostic accuracy for patient care. Association for Molecular Pathology and American Society for Investigative Pathology. Published by Elsevier Inc. 2021-09 2021-06-08 /pmc/articles/PMC8186061/ /pubmed/34116245 http://dx.doi.org/10.1016/j.jmoldx.2021.05.015 Text en © 2021 Association for Molecular Pathology and American Society for Investigative Pathology. Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Regular Article Martinez, Ryan J. Pankratz, Nathan Schomaker, Matthew Daniel, Jerry Beckman, Kenneth Karger, Amy B. Thyagarajan, Bharat Ferreri, Patricia Yohe, Sophia L. Nelson, Andrew C. Prediction of False-Positive Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Molecular Results in a High-Throughput Open-Platform System |
title | Prediction of False-Positive Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Molecular Results in a High-Throughput Open-Platform System |
title_full | Prediction of False-Positive Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Molecular Results in a High-Throughput Open-Platform System |
title_fullStr | Prediction of False-Positive Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Molecular Results in a High-Throughput Open-Platform System |
title_full_unstemmed | Prediction of False-Positive Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Molecular Results in a High-Throughput Open-Platform System |
title_short | Prediction of False-Positive Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Molecular Results in a High-Throughput Open-Platform System |
title_sort | prediction of false-positive severe acute respiratory syndrome coronavirus 2 (sars-cov-2) molecular results in a high-throughput open-platform system |
topic | Regular Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186061/ https://www.ncbi.nlm.nih.gov/pubmed/34116245 http://dx.doi.org/10.1016/j.jmoldx.2021.05.015 |
work_keys_str_mv | AT martinezryanj predictionoffalsepositivesevereacuterespiratorysyndromecoronavirus2sarscov2molecularresultsinahighthroughputopenplatformsystem AT pankratznathan predictionoffalsepositivesevereacuterespiratorysyndromecoronavirus2sarscov2molecularresultsinahighthroughputopenplatformsystem AT schomakermatthew predictionoffalsepositivesevereacuterespiratorysyndromecoronavirus2sarscov2molecularresultsinahighthroughputopenplatformsystem AT danieljerry predictionoffalsepositivesevereacuterespiratorysyndromecoronavirus2sarscov2molecularresultsinahighthroughputopenplatformsystem AT beckmankenneth predictionoffalsepositivesevereacuterespiratorysyndromecoronavirus2sarscov2molecularresultsinahighthroughputopenplatformsystem AT kargeramyb predictionoffalsepositivesevereacuterespiratorysyndromecoronavirus2sarscov2molecularresultsinahighthroughputopenplatformsystem AT thyagarajanbharat predictionoffalsepositivesevereacuterespiratorysyndromecoronavirus2sarscov2molecularresultsinahighthroughputopenplatformsystem AT ferreripatricia predictionoffalsepositivesevereacuterespiratorysyndromecoronavirus2sarscov2molecularresultsinahighthroughputopenplatformsystem AT yohesophial predictionoffalsepositivesevereacuterespiratorysyndromecoronavirus2sarscov2molecularresultsinahighthroughputopenplatformsystem AT nelsonandrewc predictionoffalsepositivesevereacuterespiratorysyndromecoronavirus2sarscov2molecularresultsinahighthroughputopenplatformsystem |